Yinxia Wei
Overview
Explore the profile of Yinxia Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang L, Song Z, Wei Y
Front Psychol
. 2024 Sep;
15:1425061.
PMID: 39282667
Reflexive interpretation is a pivotal aspect of discourse comprehension, which usually reveals consistent challenges for Chinese EFL learners. These learners often breach the locality constraint of reflexive pronouns, exhibiting a...
2.
Su M, Hou Y, Cai S, Li W, Wei Y, Wang R, et al.
Diabetologia
. 2024 Feb;
67(5):850-863.
PMID: 38413438
Aims/hypothesis: Type 2 diabetes mellitus is known to contribute to the development of heart failure with preserved ejection fraction (HFpEF). However, identifying HFpEF in individuals with type 2 diabetes early...
3.
Cai S, Chang J, Su M, Wei Y, Sun H, Chen C, et al.
Cell Mol Life Sci
. 2023 Nov;
80(12):359.
PMID: 37951845
Pathological cardiac remodeling plays an essential role in the progression of cardiovascular diseases, and numerous microRNAs have been reported to participate in pathological cardiac remodeling. However, the potential role of...
4.
Cai S, Huang F, Wang R, Wu M, Liu M, Peng Y, et al.
Front Cardiovasc Med
. 2023 Jun;
10:1174466.
PMID: 37378408
Purpose: This study evaluates the association between habitual physical activity (HPA) and the outcomes of patients with myocardial infarction (MI). Methods: Patients newly diagnosed with MI were divided into two...
5.
Liao J, Wei D, Sun C, Yang Y, Wei Y, Liu X
BMC Nephrol
. 2022 Dec;
23(1):393.
PMID: 36482367
Background: Hemodialysis (HD) is the most important renal replacement therapy for patients with end-stage kidney disease (ESKD). Systemic inflammation is a risk factor of mortality in HD patients. Neutrophil-to-lymphocyte ratio...